MedPath

COLORADO BLOOD CANCER INSTITUTE

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
https://bloodcancerinstitute.com/

Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression

Phase 3
Conditions
Graft Versus Host Disease
Interventions
First Posted Date
2014-07-01
Last Posted Date
2014-07-01
Lead Sponsor
Colorado Blood Cancer Institute
Target Recruit Count
50
Registration Number
NCT02178683
Locations
🇺🇸

Colorado Blood Cancer Institute, Denver, Colorado, United States

Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant

Phase 2
Conditions
Graft Failure
Interventions
Procedure: Allogeneic hematopoietic stem cell graft using an allogeneic SCT HLA-Identical or non-identical family donor or unrelated donors
Drug: fludarabine
Procedure: TBI
First Posted Date
2007-05-11
Last Posted Date
2014-06-30
Lead Sponsor
Colorado Blood Cancer Institute
Target Recruit Count
20
Registration Number
NCT00472329
Locations
🇺🇸

Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado, United States

Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation

Phase 2
Conditions
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Chronic Myeloid Leukemia
Non-Hodgkin Lymphoma
Myelodysplastic Syndromes
First Posted Date
2006-05-19
Last Posted Date
2006-06-26
Lead Sponsor
Colorado Blood Cancer Institute
Target Recruit Count
20
Registration Number
NCT00328237
Locations
🇺🇸

Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado, United States

Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor

Phase 2
Conditions
Multiple Myeloma
Lymphoma
Acute Myelogenous Leukemia
Acute Lymphocytic Leukemia
Myelodysplastic Syndrome
First Posted Date
2006-03-20
Last Posted Date
2008-02-08
Lead Sponsor
Colorado Blood Cancer Institute
Target Recruit Count
40
Registration Number
NCT00304720
Locations
🇺🇸

Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath